Cellosaurus cell line F2N78 (CVCL_VK71)

PubMed=23296943; DOI=10.1002/btpr.1685
Lee H.-J., Chang M., Kim J.-M., Hong H., Maeng K.E., Koo J., Chang S.-J., Cho M.-S.
Application of a new human cell line, F2N78, in the transient and stable production of recombinant therapeutics.
Biotechnol. Prog. 29:432-440(2013)

PubMed=26454770; DOI=10.1016/j.jbiosc.2015.07.007
Seo J.S., Min B.S., Kwon Y.-B., Lee S.-Y., Cho J.-M., Park K.-H., Yang Y.J., Maeng K.E., Chang S.-J., Kim D.-I.
Characteristics of human cell line, F2N78, for the production of recombinant antibody in fed-batch and perfusion cultures.
J. Biosci. Bioeng. 121:317-324(2016)

PubMed=28054185; DOI=10.1007/s10529-016-2281-2
Seo J.S., Min B.S., Kim Y.J., Cho J.M., Kwon G.-S., Lim B.-P., Chang S.-J., Kim D.-I.
Characterization of human hybrid cell line, F2N78, through a comparison of culture performances and protein qualities.
Biotechnol. Lett. 39:501-509(2017)